Search
Patexia Research
Case number 1:17-cv-00824

Biogen International GmbH et al v. Aurobindo Pharma U.S.A., Inc. et al > Documents

Date Field Doc. No.Description (Pages)
Jul 8, 2020 1 Complaint (13)
Nov 26, 2019 23 Patent/Trademark Report to Commissioner (1)
Nov 26, 2019 23 Main Document (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # (1) Stipulation of Dismissal)(mdb)
Nov 26, 2019 23 Stipulation of Dismissal (3)
Nov 26, 2019 N/A Terminated Case (0)
Docket Text: CASE CLOSED per D.I. 341 in Lead Case 17-823. (dlw)
Nov 13, 2019 N/A Case Assigned/Reassigned (0)
Docket Text: Case Reassigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. Associated Cases: 1:17-cv-00823-MN through 1:17-cv-00825-MN, 1:17-cv-00828-MN, 1:17-cv-00845-MN through 1:17-cv-00847-MN, 1:17-cv-00849-MN through 1:17-cv-00857-MN, 1:17-cv-00872-MN, 1:17-cv-00874-MN, 1:17-cv-00875-MN, 1:17-cv-00954-MN, 1:18-cv-00337-MN, 1:18-cv-00623-MN, 1:18-cv-01361-MN, 1:19-cv-00303-MN, and 1:19-cv-00333-MN (rjb)
Feb 28, 2019 22 Notice of Change of Address (1)
Docket Text: NOTICE of Change of Address by Arthur G. Connolly, III (Connolly, Arthur)
Feb 2, 2018 N/A Create Case Association (0)
Docket Text: Case associated with lead case: Create association to 1:17-cv-00823-LPS. Associated Cases: 1:17-cv-00824-LPS et al. (ntl)
Feb 2, 2018 N/A Case Referred to Mediation (0)
Docket Text: CASE REFERRED to Magistrate Judge Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:17-cv-00824-LPS et al.(dlb)
Jan 31, 2018 21 Proposed Order (22)
Docket Text: PROPOSED ORDER (Proposed Scheduling Order) by Biogen International GmbH, Biogen MA Inc.. (Balick, Steven)
Jan 31, 2018 20 Letter (1)
Docket Text: Letter to The Honorable Leonard P. Stark from Steven J. Balick regarding the Parties' Proposed Scheduling Order. (Balick, Steven)
Jan 23, 2018 19 Transcript (35)
Docket Text: Official Transcript of Scheduling Telephone Conference held on January 17, 2018 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Telephone No. (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 2/13/2018. Redacted Transcript Deadline set for 2/23/2018. Release of Transcript Restriction set for 4/23/2018.(bpg)
Jan 17, 2018 N/A Telephone Conference (0)
Docket Text: Minute Entry for proceedings held before Judge Leonard P. Stark - Telephone Conference held on 1/17/2018. (Court Reporter B. Gaffigan.) Associated Cases: 1:17-cv-00823-LPS et al. (ntl)
Dec 28, 2017 N/A Oral Order (0)
Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that a Rule 16 scheduling teleconference has been scheduled for January 17, 2018 at 9:30 AM. Plaintiffs counsel shall initiate the teleconference call to 302-573-4571. No further submissions are necessary. ORDERED by Judge Leonard P. Stark on 12/28/2017. Associated Cases: 1:17-cv-00823-LPS et al.(etg)
Dec 20, 2017 17 Proposed Order (25)
Docket Text: PROPOSED ORDER (Proposed Scheduling Order) by Biogen International GmbH, Biogen MA Inc.. (Balick, Steven)
Dec 20, 2017 16 Letter (1)
Docket Text: Letter to The Honorable Leonard P. Stark from Steven J. Balick regarding the Parties' Proposed Scheduling Order. (Balick, Steven)
Dec 20, 2017 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (15 in 1:17-cv-00824-LPS, 14 in 1:17-cv-00856-LPS, 14 in 1:17-cv-00872-LPS, 14 in 1:17-cv-00848-LPS, 14 in 1:17-cv-00849-LPS, 17 in 1:17-cv-00845-LPS, 16 in 1:17-cv-00846-LPS, 12 in 1:17-cv-00847-LPS, 15 in 1:17-cv-00851-LPS, 15 in 1:17-cv-00823-LPS, 15 in 1:17-cv-00852-LPS, 16 in 1:17-cv-00857-LPS, 16 in 1:17-cv-00828-LPS, 17 in 1:17-cv-00875-LPS, 13 in 1:17-cv-01361-LPS, 19 in 1:17-cv-00825-LPS, 15 in 1:17-cv-00829-LPS, 15 in 1:17-cv-00855-LPS, 17 in 1:17-cv-00827-LPS, 17 in 1:17-cv-00853-LPS, 16 in 1:17-cv-00826-LPS, 15 in 1:17-cv-00874-LPS, 12 in 1:17-cv-00954-LPS, 14 in 1:17-cv-00854-LPS, 17 in 1:17-cv-00850-LPS) STIPULATION Seeking to Extend the Deadline by Which the Parties Must Submit a Proposed Scheduling Order, by Biogen International GmbH, Biogen MA Inc. Signed by Judge Leonard P. Stark on 12/20/2017. Associated Cases: 1:17-cv-00823-LPS et al.(etg)
Dec 19, 2017 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Steven J. Moore for Aurobindo Pharma U.S.A., Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg)
Dec 18, 2017 N/A SO ORDERED (0)
Dec 15, 2017 15 Stipulation (12)
Docket Text: STIPULATION Seeking to Extend the Deadline by Which the Parties Must Submit a Proposed Scheduling Order, by Biogen International GmbH, Biogen MA Inc.. (Balick, Steven)
Dec 15, 2017 14 Motion for Leave to Appear Pro Hac Vice (3)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Steven J. Moore of Withers Bergman LLP - filed by Aurobindo Pharma U.S.A., Inc., Aurobindo Pharma USA LLC. (Connolly, Arthur)
Nov 29, 2017 N/A Order (0)
Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that the parties shall confer regarding proposed dates in the scheduling order and shall submit a proposal, including a proposal for the length and timing of trial, to the Court no later than December 15, 2017. The parties are to review the Court's form scheduling order, which is posted at http://www.ded.uscourts.gov (see Chambers, Judge Stark, New Patent Procedures). ORDERED by Judge Leonard P. Stark on 11/29/17. Associated Cases: 1:17-cv-00823-LPS et al. (ntl)
Nov 13, 2017 12 Answer to Counterclaim (6)
Docket Text: ANSWER to [10] Answer to Complaint, Counterclaim by Biogen International GmbH, Biogen MA Inc..(Mayo, Andrew)
Nov 7, 2017 N/A SO ORDERED (0)
Nov 6, 2017 11 Stipulation to EXTEND Time (9)
Docket Text: STIPULATION TO EXTEND TIME for Plaintiffs to Respond to Defendants' Counterclaims to November 13, 2017 - filed by Biogen International GmbH, Biogen MA Inc.. (Mayo, Andrew)
Oct 16, 2017 10 Answer to Complaint (30)
Docket Text: ANSWER to [1] Complaint, Separate Defenses, COUNTERCLAIM to Complaint filed 06/26/17 against Biogen International GmbH, Biogen MA Inc. by Aurobindo Pharma U.S.A., Inc., Aurobindo Pharma USA LLC.(Connolly, Arthur)
Aug 29, 2017 N/A Add Attorneys Pro Hac Vice (0)
Aug 4, 2017 N/A Add Attorneys Pro Hac Vice (0)
Aug 3, 2017 N/A Add Attorneys Pro Hac Vice (0)
Aug 3, 2017 N/A Add Attorneys Pro Hac Vice (0)
Aug 3, 2017 N/A Add Attorneys Pro Hac Vice (0)
Jul 28, 2017 N/A SO ORDERED (0)
Jul 26, 2017 9 Stipulation to EXTEND Time (1)
Docket Text: STIPULATION TO EXTEND TIME to Respond to the Complaint to October 16, 2017 - filed by Biogen International GmbH, Biogen MA Inc.. (Balick, Steven)
Jul 26, 2017 N/A SO ORDERED (0)
Jul 24, 2017 8 Motion for Leave to Appear Pro Hac Vice (14)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Sanya Sukduang, Li Feng, and Andrew E. Renison - filed by Biogen International GmbH, Biogen MA Inc.. (Mayo, Andrew)
Jul 21, 2017 7 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Biogen Inc. for Biogen International GmbH, Biogen MA Inc. filed by Biogen International GmbH, Biogen MA Inc.. (Mayo, Andrew)
Jun 28, 2017 N/A Case Assigned/Reassigned (0)
Jun 27, 2017 6 Summons Returned Executed (2)
Docket Text: SUMMONS Returned Executed by Biogen MA Inc., Biogen International GmbH. Aurobindo Pharma USA LLC served on 6/27/2017, answer due 7/18/2017. (Balick, Steven)
Jun 27, 2017 5 Summons Returned Executed (2)
Docket Text: SUMMONS Returned Executed by Biogen MA Inc., Biogen International GmbH. Aurobindo Pharma U.S.A., Inc. served on 6/27/2017, answer due 7/18/2017. (Balick, Steven)
Jun 27, 2017 N/A Summons Issued (0)
Docket Text: Summons Issued with Magistrate Consent Notice attached as to Aurobindo Pharma U.S.A., Inc. on 6/27/2017; Aurobindo Pharma USA LLC on 6/27/2017. (ceg)
Jun 26, 2017 N/A No Summons Issued (0)
Docket Text: No Summons Issued. (nmg)
Jun 26, 2017 4 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,320,999; 8,399,514. (nmg)
Jun 26, 2017 3 ANDA Form (2)
Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: See Attached. Date of Expiration of Patent: See Attached. (nmg)
Jun 26, 2017 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg)
Jun 26, 2017 1 Civil Cover Sheet (2)
Jun 26, 2017 1 Exhibit B (30)
Jun 26, 2017 1 Main Document (13)
Docket Text: COMPLAINT for PATENT INFRINGEMENT filed against Aurobindo Pharma U.S.A., Inc., Aurobindo Pharma USA LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2171373.) - filed by Biogen MA Inc., Biogen International GmbH. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Civil Cover Sheet)(nmg)
Jun 26, 2017 1 Exhibit A (8)
Jun 26, 2017 1 Complaint* (1)
Menu